Biotech Rips On Topline Analysis

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, February 11, 2025

A biotech company is turning heads so far during Tuesday’s session after it shared topline analysis of its Phase 2a dose-ranging trial of LP-310, a liposomal-tacrolimus oral rinse formulation of LP-10 being developed to treat oral lichen planus (OLP), according to a press release.

Traders rushed to scoop up shares of Lipella Pharmaceuticals Inc. (Nasdaq:LIPO) at the open, pushing this micro cap up to $4.69/share (+5377%) at the early session high. This move was a strong confirmation of the recent breakout from its multi-month downtrend.

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.

Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Two Micro-Caps In The AI Sector Make Significant Announcements

This Micro Cap Found Mid-Week Success On New Clinical Data

Biotech Rips On Topline Analysis

Monday Moves From Mineral Exploration Junior Miner

No Headlines, No Problem: Why Technical Analysis Still Moves Stocks

Mineral Explorer Signs LOI, Sending Shares Higher

Trump’s acting CFPB chief halts all supervision of companies

Early Crypto Traders Had Speedy Profit on Trump Coin as Others Suffered Losses

AllPennyStocks.com Favorites

This Chinese Micro Cap Could Be A Serious Outperformer

Enable Free Access to Unlock Up to Two Articles Per Month.

Markets on Edge as Tariffs Remain in Headlines

Enable Free Access to Unlock Up to Two Articles Per Month.

Trading on the Nasdaq, Metalpha Technology Holding Limited displayed a Golden Cross (50 DMA / 200 DMA) on Tuesday. Closing at $1.92, the stock has the technical “green light” for potential gains.

Predictmedix AI Inc. was a standout on the Canadian Securities Exchange on Tuesday. Shares rose 66.67%, closing at $0.03.

Tuesday's hottest penny Stock on the Nasdaq was Omega Therapeutics Inc., which gained 78.98%, closing the day at $0.19.

Rinse and Repeat; Looking for Another Hefty Profit Again with This Stock

Enable Free Access to Unlock Up to Two Articles Per Month.

This Media Stock Is Setting Up For Its Next Move

Enable Free Access to Unlock Up to Two Articles Per Month.

WANT TO UNLOCK ACCESS TO:

●Stock Picks

●Penny Stocks to Watch

●"By The Numbers" Data Analytics

●Market Commentary

●Watch Lists

And much more by becoming an AllPennyStocks.com Free Member.

Free Membership Has Its Perks!

By entering your email address, you agree to AllPennyStocks.com’s disclaimer and privacy policy.

Register via:

You understand that AllPennyStocks.com and its affiliates may use your address to send updates, ads and offers.

Go Back

Email Registration

By clicking on the "Start Viewing AllPennyStocks.com Pro Articles" button below, you are confirming that you understand and accept that the content we are showing you is not meant to be used as financial advice. This content is merely for educational purposes and shows our readers real-time examples of trading strategies based on technical and fundamental analysis principles, along with stock market commentary.

Investing in stocks is risky stuff, trust us on that one, and past performance may not be indicative of future performance.

We want everyone to enjoy this information for its educational value, and we remind everyone that we are not liable for losses or damages of any kind from trading based on our information. The only thing we will recommend is to consult with a financial advisor prior to making any trades.

With that said, if we're on the same page here and you agree to our disclaimer, click the button below and enjoy all of our AllPennyStocks.com Pro content.

© Copyright 2025 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.

Biotech Rips On Topline Analysis

Other Penny Stock Movers

Two Micro-Caps In The AI Sector Make Significant Announcements

This Micro Cap Found Mid-Week Success On New Clinical Data

Biotech Rips On Topline Analysis

Most Popular

AllPennyStocks.com Favorites